GeoPolitics Pulse

The Heartbeat of World events

European Commission approves aflibercept biosimilar OPUVIZ (previously SB15) from …

by ·

The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar referencing Eylea (aflibercept) …Read More

Related posts:

  1. Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the …
  2. European Commission approves Celltrion’s SteQeyma ® (CT-P43), a biosimilar to Stelara …
  3. European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara …
  4. European Commission Approves Biocon Biologics’ Ustekinumab Biosimilar
  5. Celltrion Expands Biosimilar Portfolio in the European Union Following European … – Business Wire